Publications

Balancing IL-17–mediated protection and IFN-γ–driven pathology at mucocutaneous barriers

 445
Balancing IL-17–mediated protection and IFN-γ–driven pathology at mucocutaneous barriers

Tags:

Previous Article

Astrocytes are critical for fear memory

Next Article

Controlling mucocutaneous barriers by cytokines

Related Posts

Multiscale proteomic modeling reveals protein networks driving Alzheimer’s disease pathogenesis

Multiscale proteomic modeling reveals protein networks ...

 50

Targeting RhoA nuclear mechanoactivity rejuvenates aged hematopoietic stem cells

Targeting RhoA nuclear mechanoactivity rejuvenates aged...

 33

Microbial metabolism of food allergens determines the severity of IgE-mediated anaphylaxis

Microbial metabolism of food allergens determines the s...

 18